|
@ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹ |
<< Šw‰ïŽ‚Ö–ß‚é
<< ‘O‚̃y[ƒW‚Ö–ß‚é
‘æ89‰ñŠwpW‰ïi•½¬7”N6ŒŽ11“új
yˆê”ʉ‰‘èz
•wl‰Èi1j Žq‹{èò•”Œ´”‚ÌEndocrine carcinoma‚Ì1Ç—á
•ˆä@–ƒ‹I, ‰Æ‰i@‘, ˆéè@‘¾ˆê, ŽáŒŽ@‰ë”ü, •“à@–±, ˆÉ“Œ@ŒbŽq, “c’†@ƒ–ç, “c’†@², ²X–Ø@–Î
“ú–{ˆã‰È‘åŠw•‘®‘½–€‰iŽR•a‰@ŽY•wl‰È
“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 32(2)
232-232, 1995
|